1. Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
- Author
-
Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Irene Suarez-Pereira, Paula Iruzubieta, María Teresa Arias-Loste, Esther Setién-Suero, Rosa Ayesa-Arriola, Marcos Gómez-Revuelta, Javier Crespo, and Benedicto Crespo Facorro
- Subjects
Computer applications to medicine. Medical informatics ,R858-859.7 ,Science (General) ,Q1-390 - Abstract
The presented article describes data from secondary analyses, related to the research article entitled “Cannabis consumption and Non-Alcoholic Fatty Liver Disease. A three years longitudinal study in first episode non-affective psychosis patients” [1]. We present detailed data regarding the socio-demographic and baseline clinical characteristics of a sample of 390 drug-naïve patients with a first episode of non-affective psychosis, and the differences between cannabis users and non-users in those characteristics. Tables also show the results from cross-sectional and longitudinal statistical analyses exploring the relation between cannabis consumption and liver function, after excluding those patients with hazardous alcohol drinking. Keywords: Cannabis, Psychosis, Liver, Liver steatosis, NAFLD, Antipsychotic treatment, Mental health
- Published
- 2019
- Full Text
- View/download PDF